article thumbnail

A single hormone directs body’s responses to low-protein diet

Scienmag

A single hormone appears to coordinate the lifespan extension produced by a low-protein diet. A single hormone appears to coordinate the lifespan extension produced by a low-protein diet. BATON ROUGE, LA. – Credit: Pennington Biomedical Research Center BATON ROUGE, LA. –

article thumbnail

Prostate cancer hijacks tumor cell biorhythm to evade hormone therapy

Scienmag

Hormone therapy is successful at keeping metastatic prostate cancer under control, but eventually the tumor cells become resistant to it. An unexpected potential solution has now emerged in medicines not designed to fight cancer, but to target proteins that regulate a cell’s circadian rhythm.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Exercise hormone may modulate genes associated with replication of novel coronavirus

Scienmag

Brazilian researchers observed that in uninfected adipocytes, the hormone irisin altered the expression of genes that regulate ACE-2, which encodes a protein to which the virus binds in order to invade human cells.

article thumbnail

NICE supports Theramex’s Eladynos for post-menopause osteoporosis

Pharmaceutical Technology

Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.

Hormones 130
article thumbnail

New research data on the regulation of hormone-dependent breast cancer

Scienmag

Notch proteins are key regulators of growth and differentiation of both normal and cancer cells. These results can be used in the development of new cancer treatments, especially for hormone-dependent breast cancer.

article thumbnail

FDA accepts AstraZeneca’s NDA for breast cancer combination therapy

Pharmaceutical Technology

The combination therapy is intended to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in adult patients, after recurrence or progression on or after an endocrine-based regimen. AstraZeneca stated that its NDA is being reviewed under Project Orbis.

HR 245
article thumbnail

Researcher identifies 6,000 sperm proteins, potentially leading to male contraceptive

Medical Xpress

A researcher has for the first time profiled 6,000 sperm proteins that could help create a non-hormonal male contraceptive—while also building on key research linking sperm health to overall men's health.

Protein 75